SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020

Arokiaswamy Velumani, Chaitali Nikam, Wilson Suraweera, Sze Hang Fu, Hellen Gelband, Patrick Brown, Isaac Bogoch, Nico Nagelkerke, Prabhat Jha
doi: https://doi.org/10.1101/2021.03.19.21253429

Article usage

Article usage: March 2021 to November 2024

AbstractFullPdf
Mar 20215401786
Apr 2021352459102
May 2021396579533
Jun 202135769198
Jul 202123650300
Aug 202116150119
Sep 20211601546
Oct 20211023063
Nov 20211123244
Dec 20211481737
Jan 20221033232
Feb 2022772031
Mar 202254810
Apr 2022552848
May 2022491219
Jun 202225776
Jul 202228465
Aug 202236713
Sep 202253712
Oct 202241710
Nov 20222425
Dec 202225919
Jan 202329613
Feb 202323411
Mar 20232037
Apr 202325520
May 202322310
Jun 202316811
Jul 20231525
Aug 202320128
Sep 202319515
Oct 20231349
Nov 202337245
Dec 20231446
Jan 202415106
Feb 2024161011
Mar 20242187
Apr 2024141515
May 20241534
Jun 202424129
Jul 20241276
Aug 202422912
Sep 2024301012
Oct 20241878
Nov 20249411
Back to top
Posted March 24, 2021.
Download PDF

Supplementary Material

Data/Code
Email
SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020
Arokiaswamy Velumani, Chaitali Nikam, Wilson Suraweera, Sze Hang Fu, Hellen Gelband, Patrick Brown, Isaac Bogoch, Nico Nagelkerke, Prabhat Jha
medRxiv 2021.03.19.21253429; doi: https://doi.org/10.1101/2021.03.19.21253429
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area